Dichloroacetate Sodium (DCA)
DCA is an old drug that has been studied extensively in humans for treatment of a rare disease called “congenital lactic acidosis.” It has some mild to moderate side effects which are much milder than conventional chemotherapy. New research shows that DCA can induce the death of the following human cancer cells in the lab:
brain cancer (glioblastoma)
lung cancer (non-small cell)
Our observational data strongly suggests that DCA works in patients with many types of cancer (including but not limited to the above cancers), even those who have failed multiple conventional treatments.
Click here for details about Medicor’s DCA treatment program, and here to read some exciting case reports.